Adenosine as inhibitor of myocardial effects of catecholamines
- PMID: 201920
- DOI: 10.1007/BF00582203
Adenosine as inhibitor of myocardial effects of catecholamines
Abstract
Infusion of adenosine into the coronary arteries of isolated guinea pig hearts produced a dose-dependent inhibition of dP/dtmax caused by bolus injections of isoproterenol (4 X 10(-11) moles). Threshold concentration of adenosine was 10(-7) M and maximal inhibition (90%) occurred at 10(-5) M. Coronary dilation induced by papaverine did not influence the contractile response to catecholamines. In addition to its influence on cardiac performance, adenosine (10(-5) M) effectively inhibited the isoproterenol (10(-7)M) induced initial rise in myocardial levels of cyclic 3'5'-AMP, glucose-1-phosphate and glucose-6-phosphate. Adenosine also antagonized the effect of isoproterenol on adenylate cyclase activity in a crude membrane preparation from guinea pig ventricles; it was without effect on the activity of the membrane phosphodiesterase. Theophylline inhibited the actions of adenosine both on adenylate cyclase activity and on contractile force development. Upon infusion of isoproterenol (3 X 10(-7)M) into the coronary arteries of the isolated heart (perfusion at constant pressure), the adenosine concentration in the effluent perfusate increased within 45 s from 10(-8) M to about 10(-6) M. It thus appears conceivable that in ventricular myocardium endogenously formed adenosine may serve 2 functions: dilation of the coronary arteries and limitation of the inotropic and metabolic effects of catecholamines.
Similar articles
-
Inhibitory action of adenosine on histamine- and dopamine-stimulated cardiac contractility and adenylate cyclase in guinea pigs.Circ Res. 1981 Feb;48(2):259-66. doi: 10.1161/01.res.48.2.259. Circ Res. 1981. PMID: 6257419
-
Persistent desensitization of the heart to the inotropic action of isoproterenol by adenosine.Res Commun Chem Pathol Pharmacol. 1989 Nov;66(2):233-54. Res Commun Chem Pathol Pharmacol. 1989. PMID: 2602656
-
Role of extracellular and intracellular adenosine in the attenuation of catecholamine evoked responses in guinea pig heart.J Mol Cell Cardiol. 1984 Sep;16(9):813-22. doi: 10.1016/s0022-2828(84)80005-x. J Mol Cell Cardiol. 1984. PMID: 6092651
-
Effects of adenosine analogues on force and cAMP in the heart. Influence of adenosine deaminase.Eur J Pharmacol. 1989 May 19;164(2):179-87. doi: 10.1016/0014-2999(89)90457-3. Eur J Pharmacol. 1989. PMID: 2547633
-
The cardiac effects of adenosine.Prog Cardiovasc Dis. 1989 Jul-Aug;32(1):73-97. doi: 10.1016/0033-0620(89)90015-7. Prog Cardiovasc Dis. 1989. PMID: 2664879 Review. No abstract available.
Cited by
-
Pharmacological characteristics of adenosine-induced inhibition of dog ventricular contractility: dependence on the pre-existing level of beta-adrenoceptor activation.Naunyn Schmiedebergs Arch Pharmacol. 1991 Jul;344(1):70-8. doi: 10.1007/BF00167384. Naunyn Schmiedebergs Arch Pharmacol. 1991. PMID: 1685559
-
Proceedings of the British Pharmacological Society. Cardiff, 10th-12th April, 1985. Abstracts.Br J Pharmacol. 1985 Jun;85 Suppl(Suppl):204P-393P. Br J Pharmacol. 1985. PMID: 4016435 Free PMC article. No abstract available.
-
Possible role of prostaglandins in the regulation of coronary blood flow.Basic Res Cardiol. 1981 May-Jun;76(3):239-49. doi: 10.1007/BF01907769. Basic Res Cardiol. 1981. PMID: 6268056
-
Differences in the regional distribution and response to ischaemia of adenosine-regulating enzymes in the heart.Basic Res Cardiol. 1987 Nov-Dec;82(6):576-84. doi: 10.1007/BF01907228. Basic Res Cardiol. 1987. PMID: 2829814
-
Antagonism of novel inotropic agents at A1 adenosine receptors and m-cholinoceptors in human myocardium.Naunyn Schmiedebergs Arch Pharmacol. 1990 Jun;341(6):577-85. doi: 10.1007/BF00171739. Naunyn Schmiedebergs Arch Pharmacol. 1990. PMID: 2392160
References
MeSH terms
Substances
LinkOut - more resources
Other Literature Sources